Fibrinolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in latino women with previous gestational diabetes

Diabetes Research and Clinical Practice

Volumn 78, Issue 3, 2007, Pages 340-348

  Morimitsu, Lilian K ^a   Fusaro, Annunciata S ^a   Sanchez, Victor H ^a   Hagemann, Cristiane C F ^a   Bertini, Anna Maria ^a   Dib, Sergio A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Fibrinolytic dysfunction; Gestational diabetes mellitus; Impaired glucose tolerance; Insulin resistance; PAI 1

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PUERPERIUM;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FIBRINOLYSIS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; ITALY; LIPIDS; LIPOPROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTPARTUM PERIOD; PREGNANCY; REFERENCE VALUES;

EID: 35649000865     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.04.013     Document Type: Article

References (45)

1. Buchanan T., and Catalano P.M. The pathogenesis of GDM: implication for diabetes after pregnancy. Diabetes Rev. 3 (1995) 584-601
2. Metzer B.E. Summary and recommendations of the third international workshop-conference on gestational diabetes. Diabetes 40 Suppl. 2 (1991) 197-201
3. Clark Jr. C.M., Qiu C., Amerman B., Porter B., Fineberg N., et al. Gestational diabetes: should it be added to the syndrome of insulin resistance?. Diabetes Care 20 (1997) 867-871
4. Reaven G.M. Banting lecture: role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
5. Nielsen H.B. General characteristics of the insulin resistance syndrome. The EGIR Database, Cannes Symposium (1998)
6. Kim C., Newton K.M., and Knopp R.H. Gestational diabetes and the incidence of type-2 diabetes: a systematic review. Diabetes Care 25 (2002) 1862-1868
7. Loskutoff D.J., Sawdey M., and Mimuro J. Type 1 plasminogen activator inhibitor. Prog. Hemost. Thromb. 9 (1988) 87-115
8. Loskutoff D.J., Sawdey M., Keeton M., and Schneiderman J. Regulation of PAI-1 gene expression in vivo. Thromb. Haemost. 70 1 (1993) 135-137
9. Sprengers E.D., and Kluft C. Plasminogen activator inhibitors. Blood 69 (1987) 381-387
10. Hamsten A., de Faire U., Walldius G., Dahlen G., Szamosi A., Landou C., et al. Plasminogen adtivator inhibitor in plasma: risk factor of recurrent myocardial infarction. Lancet II (1987) 3-9
11. Gürlek A., Bayraktar M., and Kirazli S. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients. Diabetes Care 23 (2000) 88-92
12. Gray R.P., Yudkin J.S., and Patterson D.L.H. Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic subjects. Br. Heart J. 69 (1993) 228-232
13. Gray R.P., Patterson D.H.L., and Yudkin J.S. Plasminogen activator inhibitor activity in diabetic and non-diabetic survivors of myocardial infarction. Arterioscler. Thromb. 13 (1993) 415-420
14. Juhan-Vague I., Roul C., Alessi M.C., Ardissone J.P., Heim M., and Vague P. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic subjects: relationship with plasma insulin. Thromb. Haemost. 61 (1989) 370-373
15. van Loon B., Potter J., Kluft C., Radder J.K., Blankenstein M.A., and Meinders A.E. The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism 42 (1993) 945-949
16. Festa A., D'Agostino, Tracy R.P., and Haffner S.M. Elevated levels of acute-phase proteins and plasminogen activator-inhibitor-1 predict the development of type 2 diabetes. The Insulin Resistance Atherosclerosis Study. Diabetes 51 (2002) 1131-1137
17. Kruithof E.K.O., Tran-Thang C., Gudinchet A., Hauert J., Nicoloso G., Genton C., et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 69 (1987) 460-466
18. Inglis T.C.M., Stuart J., George A.J., and Dacies J. Haemostatic and rheological changes in normal pregnancy and pre-eclampsia. Br. J. Haematol. 50 (1982) 461-465
19. Bellart J., Gilabert J., Fontcuberta J., Carreras E., Miralles R.M., and Cabero L. Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes. Am. J. Perinatol. 15 8 (1998) 479-486
20. National High Blood Pressure Education Program, Working Group Report on High Blood Pressure in Pregnancy, US Govt Printing Office, Washington, DC, 2000 (NIH Publ no. 00-3029).
21. Bonora E., Moghetti P., Zancanaro C., Cigolini M., Querena M., Cacciatori V., et al. Estimates of in vivo insulin action in man; comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J. Clin. Endocrinol. Metab. 68 (1989) 374-378
22. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: diabetes Care 20 (1997) 1183-1197.
23. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis Model Assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
24. França A.P., Bezerra D.L., Franco L.J., and Dib S.A. GAD 65 autoantibodies, beta-cell function and insulin resistance on Japanese-Brazilian adults. Centro de Estudos da Comunidade Brasileira de Bauru. Diabetes Care 23 9 (1999) 1437-1439
25. Pendergrass M., Fazioni E., and De Fronzo R.A. Non-insulin-dependent diabetes mellitus and gestational diabetes mellitus: same disease, another name?. Diabetes Rev. 3 4 (1995) 566-583
26. Buchanan T.A., Xiang A.H., Kjos S.L., Trigo E., Lee W.P., and Peters R.K. Antepartum predictors of the development of type-2 diabetes in Latin women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes 48 (1999) 2430-2436
27. Kirwan J.P., Huston-Presley L., Kalhan S.C., and Catalano P.M. Clinically useful estimates of insulin sensitivity during pregnancy. Diabetes Care 24 9 (2001) 1602-1607
28. Homko C., Sivan E., Chen X., Reece E.A., and Bolden G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 86 (2001) 568-573
29. Inchiosto S. Measurements of insulin sensitivity in type 2 diabetes mellitus: comparison between kitt and HOMA-%S indices and evaluation of their relationship with the components of the insulin resistance syndrome. Diabet. Med. 22 (2004) 39-44
30. Akinmount A., Selby P.L., Ramaiya K., and Alberti K.G.M.M. The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycemic clamp. Diabet. Med. 9 (1992) 432-437
31. De Fronzo R.A., Bonadona R.C., and Ferrannini E. Pathogenesis of NDDM. A balanced overview. Diabetes Care 15 (1992) 318-368
32. Ryan E.A., Imes S., Liu D., McManus R., Finegood D.T., Polonsky K.S., et al. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 44 (1995) 506-512
33. Knopp R.H., Chapman M., Bergelin R., Wahl P.W., Warth M.R., and Irvine S. Relationships of lipoprotein lipids to mild fasting hyperglicemia and diabetes in pregnancy. Diabetes Care 3 (1980) 416-420
34. Hollinworth D.R., and Grundy S.M. Pregnancy associated hypertriglyceridemia in normal and diabetic women. Diabetes 31 (1982) 1092-1097
35. Metzer B.E., Phelps R.L., Freinkel N., and Navickas I.A. Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids and individual aminoacids. Diabetes Care 3 (1980) 402-409
36. Kjos S.L., Buchanan T.A., Montoro M., Couslon A., and Mestaman J.H. Serum lipids within 36 months of delivery in women with recent gestational diabetes. Diabetes 40 (1991) 142-146
37. Koukkou E., Watts G.F., and Lowy C. Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J. Clin. Pathol. 49 (1996) 634-637
38. Hak-Lemmers H., Hectors M.P., Demacker P.N., Hendiks J.C., and Stalenhoef A.F. Enhnanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler. Thromb. 11 (1991) 298-306
39. Hurt-Camejo E., Camejo G., Rosengren B.E., Lopez F., Ahltron C., Fager G., et al. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler. Thromb. 12 (1992) 569-683
40. Go R.C.P., Desmond R., Roseman J.M., Bell D.S.H., Vanichanan C., and Tacton R. Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes. Diabetes Care 24 10 (2001) 1764-1769
41. Farhan S., Winzer C., Tura A., Quehenberger P., Bieglmaier C., Wagner O.F., et al. Fibrinolitic dysfunction in insulin-resistant women with previous gestational diabetes. Eur. J. Clin. Invest. 36 (2006) 345-352
42. Bastard J.P., Peironi I., and Hainkue B. Relationship between PAI-1 and insulin resistance. Diab. Metab. Res. Rev. 16 3 (2000) 192-201
43. Juhan-Vague I., Alessi M.C., and Vague P. Increased plasma plasminogen activator inhibitor-1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia 34 (1991) 457-462
44. Donahue R.P., Prineas R.J., Donahue R.D., Zimmet P., Bean Z.A., and Courten M.D. Is fasting leptin associated with insulin resistance among nondiabetic individuals?. Diabetes Care 22 (1999) 1092-1096
45. Lindhal B., Asplund K., Eliasson M., and Evrin P. Insulin resistance syndrome and fibrinolytic activity: The Northern Sweeden Monica Study. Int. J. Epidemiol. 25 (1996) 291-299